Stockreport

Entrada Therapeutics to Present at Upcoming Investor Conferences

Entrada Therapeutics, Inc.  (TRDA) 
PDF BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a clinical-stage biopharmaceutical company aiming to transform the lives of patien [Read more]